Research Study

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of RO6867461 in Patients With Diabetic Macular Edema (RHINE)
Principal Investigator 
Patrick Ma

Overview

Body Locations and Systems 
Diabetic Eye Problems
ClinicalTrials.gov# 
NCT03622593
Status 
Recruiting
Study Start/End 
Jan 17, 2019 to Sep 30, 2021
Locations 
Vancouver General Hospital
Name/Title 
Theresa Wiens, Clinical Research Manager
Phone 
604-875-4111 ext.62544
Purpose of Study 

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of faricimab administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME).

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.